RAPT   $1.78  5.33% Market Closed After Close 1.84 3.37%

RAPT Therapeutics Inc
Total Cash 114.84M
totalCashPerShare 3.29
EBITDA -127.72M
Total Debt 5.73M
quickRatio 7.759
currentRatio 8.141
Total Revenue
debtToEquity 5.244
Revenue/Share
ROA -0.46339
ROE -0.77975
grossProfits
freeCashflow -64.13M
operatingCashflow -104.88M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -45.94M
forwardPE -0.9206349
floatShares 31.55M
sharesOutstanding 34.90M
sharesShort 3.14M
sharesShortPriorMonth 3.31M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.92%
Short Ratio help_outline 11.99%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 3.129
Price To Book help_outline 0.56
earningsQuarterlyGrowth
netIncomeToCommon -120.43M
trailingEps -3.13%
forwardEps -1.89%
enterpriseToEbitda 0.36
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.56 3Q 2024
institutionsCount 154
lastUpdated Oct. 16, 2024, 8:15 p.m.